Study of YKYY032 Injection in Adults With Hyperlipoproteinemia (a)

A phase 2 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 192 participants.

Also called NCT07914660

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 2
Enrolled
  • 192 participants (planned count) (from the registry)
Sponsor
Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd. (from the registry)
Registry
  • NCT NCT07914660
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
China (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07914660. Randomized; quadruple masking; primary purpose treatment. Start 2026-11-20 (anticipated); primary completion 2028-12-30 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Study of YKYY032 Injection in Adults With Hyperlipoproteinemia (a)
Condition
Hyperlipoproteinemia (a)
Intervention (Drug)
YKYY032 group
Intervention (Other)
YKYY032 Placebo group
Lead sponsor
Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd. (class: industry)

Record details

Record id
cardio:ct-nct07914660
Content hash
d414ade576b2f3e8d74a8db21b1698adf6f0c52fe76084e5ddd0ec1c62abfb89